Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,891 | -22,333 | -16,510 | -10,724 | -6,504 |
| Depreciation Amortization | 91 | 337 | 252 | 167 | 84 |
| Accounts receivable | N/A | N/A | N/A | -1,000 | N/A |
| Accounts payable and accrued liabilities | 1,238 | -83 | -522 | -44 | 226 |
| Other Working Capital | 2,193 | -617 | -694 | -249 | 1,360 |
| Other Operating Activity | -638 | 2,220 | 2,093 | 2,053 | 260 |
| Operating Cash Flow | $-4,007 | $-20,476 | $-15,381 | $-9,797 | $-4,574 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -335 | -367 | -33 | -17 | -13 |
| Investing Cash Flow | $-335 | $-367 | $-33 | $-17 | $-13 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 715 | 715 | 715 | N/A |
| Common Stock Issued | 6,582 | 7,963 | 14 | 14 | 14 |
| Financing Cash Flow | $6,582 | $8,678 | $729 | $729 | $14 |
| Beginning Cash Position | 8,732 | 20,897 | 20,897 | 20,897 | 20,897 |
| End Cash Position | 10,972 | 8,732 | 6,212 | 11,812 | 16,324 |
| Net Cash Flow | $2,240 | $-12,165 | $-14,685 | $-9,085 | $-4,573 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,007 | -20,476 | -15,381 | -9,797 | -4,574 |
| Capital Expenditure | -335 | -367 | -33 | -17 | -13 |
| Free Cash Flow | -4,342 | -20,843 | -15,414 | -9,814 | -4,587 |